Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Haibo Cheng

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0003-3329-2225; OpenAlex author ID A5101421834.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Disea… Last author DOI 10.1002/cam4.70656↗
  2. Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. First author DOI 10.1007/s00210-015-1107-4↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Tianhao Guo · 1 shared paper, 2025
  2. Yuhan Wang · 1 shared paper, 2025
  3. Changliang Xu · 1 shared paper, 2015

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.